港股收評:恆指漲0.62%,黃金股、藥品股全天強勢,寧德時代市值超1.5萬億港元
港股三大指數集體收漲,恆生指數、國企指數分別上漲0.62%及0.84%,均刷新反彈以來新高,恆生科技指數漲0.51%,三者均錄得2連升行情,市場總體平穩、盤面上,大型科技股多數上漲但漲跌波幅不大,阿里巴巴漲超1%,快手、網易、京東、騰訊、美團漲幅皆在1%以內,百度跌近2%,小米跌0.64%;金價重返3300美元,黃金股全天表現強勢,赤峯黃金大漲近14%,招金礦業、紫金礦業、靈寶黃金漲超7%;汽車股繼續維持活躍,比亞迪股份、理想汽車均漲4%,比亞迪再創歷史新高;新冠疫情再擡頭,藥品等相關概念股集體上漲,凱萊英、三生製藥、先聲藥業漲幅居前;體育用品股、航空股、煤炭股、石油股、海運股、軍工股、手遊股普遍上漲。另一方面,濠賭股全天低迷,消費電子股、化妝品股、啤酒股、餐飲股紛紛走低。此外,寧德時代上市次日再度漲超10%,市值超1.5萬億港元。(格隆匯)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.